Heather Johnson

Contributing Writer

  • All
  • Deals
  • Devices and Diagnostics
  • Digital
  • Genetics
  • Pharma
Will a New Drug Using Cannabinoids Achieve a Breakthrough for Glaucoma?

Will a New Drug Using Cannabinoids Achieve a Breakthrough for Glaucoma?

SAN FRANCISCO – Nemus Bioscience, a biopharmaceutical company based in Southern California, came to the Glaucoma 360 New Horizons Forum here in February to make ...
Read More
How Glaucoma Device Companies Raise Funding to Navigate ‘Death Valley’

How Glaucoma Device Companies Raise Funding to Navigate ‘Death Valley’

SAN FRANCISCO – At the Glaucoma 360 New Horizons Forum here, Emmett Cunningham, Jr., MD, PhD, moderating a panel on financing for emerging glaucoma device ...
Read More
Reimbursement Hurdles in Glaucoma Space

Parsing the Challenges of Reimbursement in the Glaucoma Space: Drug and Device Developers Address Elephant in the Room

SAN FRANCISCO – When it comes to securing reimbursement models, ophthalmic device and drug developers are facing mounting pressure. Payers are demanding more evidence on ...
Read More
Glaucoma Genetics: State of the Science

The State of the Art of Glaucoma Genetics

SAN FRANCISCO – Advances in glaucoma genetics potentially hold the key to new therapies for prevention, early detection, and a cure, researcher Janey L. Wiggs, ...
Read More